Recombinant Protein Production in Plants: Biofactories for Therapeutics | PSM Publishers | Nonprofit Scientific Publishing
EDITORIAL: The infectious diseases are commonly caused by disease-causing microorganisms and it may lead to the death. The tool for recombinant proteins production is achieved by the advent of recombinant DNA technologies and these recombinant proteins are used as therapeutic agents to cure the infectious diseases. Many expression systems for the pharmaceuticals production have been developed through which various types of immunoglobulins, enzymes and edible vaccines are synthesized that are used as prophylactic or as therapeutics. Biopharmaceutical and edible vaccines derived from the plants have several advantages as it involves simple and convenient approach, provide high yield of proteins, have lower storage and production cost, the removal of the pathogen contamination, the less processing required, as well as the safe delivery of the oral vaccines (Fahad et al., 2015). In 1989, immunoglobulins derived from transgenic tobacco plant were assembled as functional antibodies (Hiatt et